Exact Mass: 452.2774

Exact Mass Matches: 452.2774

Found 54 metabolites which its exact mass value is equals to given mass value 452.2774, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Briarellin P

Briarellin P

C25H40O7 (452.2774)


   

Laserpitinol

Laserpitinol

C25H40O7 (452.2774)


   

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.2774)


   

grindelic acid 15-O-arabinoside

grindelic acid 15-O-arabinoside

C25H40O7 (452.2774)


   

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.2774)


   
   

dothideomycetone B

dothideomycetone B

C25H40O7 (452.2774)


   

5,6-acetonylgrayanotoxin-I

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.2774)


   

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.2774)


   

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.2774)


   

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.2774)


   
   

Sarcoehrendin I

methyl-9S-hydroxy-11R,15S-diacetoxy-6Z,13E-prostadienoate

C25H40O7 (452.2774)


   

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)


   

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.2774)


   

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.2774)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.2774)


   

epiandrosterone 3-beta-D-glucoside

epiandrosterone 3-beta-D-glucoside

C25H40O7 (452.2774)


A sterol 3-beta-D-glucoside that has epiandrosterone as the sterol component.

   

ST 19:0;O;GlcA

ST 19:0;O;GlcA

C25H40O7 (452.2774)


   

ST 19:1;O2;Hex

ST 19:1;O2;Hex

C25H40O7 (452.2774)


   
   

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)


   

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)


   

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)


   

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)


   

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)


   

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

C25H40O7 (452.2774)


   

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

C25H40O7 (452.2774)


   

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)


   

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)